Business
Press Release Sep 04 2025
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 04, 2025, titled "Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules (generic version of ZEPOSIA®) for the U.S. market".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 04, 2025, titled \"Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules (generic version of ZEPOSIA®) for the U.S. market\". View Attachment","length":401,"tagName":"div"}]